"10.1371_journal.pone.0014553","plos one","2011-01-21T00:00:00Z","Yann Gibert; Victoria J Lattanzi; Aileen W Zhen; Lea Vedder; Frédéric Brunet; Sarah A Faasse; Jodie L Babitt; Herbert Y Lin; Matthias Hammerschmidt; Paula G Fraenkel","Division of Hematology/Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America; Institut de Génomique Fonctionnelle de Lyon, Ecole Normale Supérieure, Lyon, France; Program in Membrane Biology, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Institute for Developmental Biology, University of Cologne, Koeln, Germany","Conceived and designed the experiments: YG PF. Performed the experiments: YG VJL AWZ LV SF PF. Analyzed the data: YG FGB PF. Contributed reagents/materials/analysis tools: JB HL MH PF. Wrote the paper: PF.","H.Y.L. and J.L.B. have ownership interest in a start-up company Ferrumax Pharmaceuticals, which has licensed technology from the Massachusetts General Hospital.","2011","01","Yann Gibert","YG",10,TRUE,2,6,3,1,TRUE,TRUE,TRUE,1,"5",FALSE
